1. Perineural dexamethasone with subsartorial saphenous nerve blocks in ACL reconstruction.
- Author
-
Chisholm MF, Cheng J, Fields KG, Marx RG, Maalouf DB, Liguori GA, Gordon MA, Zayas VM, and Yadeau JT
- Subjects
- Adult, Analgesics, Opioid therapeutic use, Anesthetics, Local administration & dosage, Bupivacaine administration & dosage, Female, Humans, Male, Middle Aged, Nerve Block adverse effects, Pain Measurement, Patient Satisfaction, Young Adult, Bone-Patellar Tendon-Bone Grafting adverse effects, Dexamethasone administration & dosage, Nerve Block methods, Pain, Postoperative prevention & control
- Abstract
Purpose: Subsartorial saphenous nerve blockade (SSNB) is an effective analgesic alternative to femoral nerve blockade after anterior cruciate ligament (ACL) reconstruction with bone-tendon-bone (BTB) autograft. It was hypothesized that dexamethasone in a SSNB will prolong analgesia, improve pain and satisfaction, and reduce postoperative opioid requirements and side effects., Methods: One hundred ninety-five patients undergoing ACL reconstruction with BTB autograft (ages 16-65) were enrolled. Subjects received SSNB with 13 ml of 0.5 % bupivacaine (control group), 1 mg preservative-free dexamethasone +0.5 % bupivacaine (treatment group I), or 4 mg preservative-free dexamethasone +0.5 % bupivacaine (treatment group II). Subjects received identical perioperative management. On postoperative days 1 and 2, subjects reported perceived block duration, pain scores, satisfaction, opioid use, and side effects. Cox-proportional hazards modelling was used to compare block duration, adjusting for body mass index, age, sex, tourniquet time, American Society of Anesthesiologists classification, and intravenous dexamethasone dose., Results: Patient-perceived block duration was significantly increased in treatment group I [hazard ratio (95 % confidence interval [CI]) 0.48 (0.31-0.75); P = 0.001] and treatment group II (hazard ratio (95 % CI): 0.52 (0.33-0.81); P = 0.004) compared to control. The block was extended from a median (95 % CI) of 33.1 (28.4-37.3) to 41.2 (32.4-50.9) and 46.5 (35.8-48.9) hours, respectively. Additionally, patients in treatment group II reported increased time that block provided pain relief, higher patient satisfaction, lower pain scores at rest, and decreased drowsiness and confusion., Conclusion: The addition of 1 and 4 mg of dexamethasone to the block injectate significantly increased SSNB duration by 8-13 h compared to control., Level of Evidence: Therapeutic study, level 1.
- Published
- 2017
- Full Text
- View/download PDF